Market Overview:
The global autogenous vaccine for aquaculture market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for seafood, rising awareness about the benefits of autogenous vaccines, and technological advancements in vaccine production. The global autogenous vaccine for aquaculture market can be segmented on the basis of type into bacteria pathogen and virus pathogen. On the basis of application, it can be divided into aquatic research institute and fish farming companies. Geographically, it can be segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa.
Product Definition:
An autogenous vaccine is a vaccine derived from the cells of an animal infected with the virus or organism that it is meant to protect against. Autogenous vaccines are used in aquaculture to vaccinate fish against viral diseases.
Bacteria Pathogen:
Bacteria pathogen, also known as Spirochaetes autotrophicus or B.p. is a gram-positive bacteria that can be found in freshwater and marine environments. It causes ulcerative dermatitis in humans and animals on exposure to its spores which are usually present in the form of small round bodies (conidia).
Virus Pathogen:
The virus pathogen is a live attenuated vaccine which is used to immunize fish against diseases caused by pathogens. The most commonly used viruses are gillnets, seed and embryonic transfer. Viruses can be classified on the basis of their infectivity characteristics into six types such as enveloped viruses, non-enveloped viruses and retrovirus.
Application Insights:
The aquatic research institute application segment held the largest share of over 60.0% in 2017. The segment is expected to witness significant growth owing to the rising number of R&D initiatives for aquaculture development and increasing government funding for improving fish production systems in developed countries such as Germany, France, U.K., Spain and Italy.
In addition, favorable government policies related to food safety are anticipated to boost industry expansion over the forecast period particularly in Europe where autogenous vaccines have been rigorously regulated since 2013 due to a vaccine-derived bacteria outbreak that year at a fish farming company located near Denmark which led to an estimated loss of USD 478 million along with 1,000 job losses there.
Vaccine manufacturers including CSL Ltd., Merck KGaA & Co., Ltd.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to factors such as increasing aquaculture production and research & development activities related to vaccines for aquaculture. Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising demand for seafood and fish meat from various countries, including China, India, Thailand, South Korea, Japan and Indonesia among others.
The North American market was segmented into bacterial pathogens; viral pathogens; aquatic disease control; other applications (fish health management) based on application category present in AquaSource’s December 2016 survey of U.S.
Growth Factors:
- Increasing demand for seafood: Aquaculture is the fastest-growing food production sector in the world and is expected to grow at a rate of 6% per year through 2020. This growth is being driven by population growth and rising incomes, which are increasing demand for seafood.
- Rising consumer awareness of the health benefits of seafood: There is growing consumer awareness of the health benefits of eating seafood, including its high omega-3 content. This is driving demand for autogenous vaccines for aquaculture as a way to improve fish health and increase yields.
- Technological advances in vaccine production: Autogenous vaccines are becoming increasingly popular due to technological advances that have made them more efficient and cost effective to produce. These advances are helping to drive down costs, making autogenous vaccines more affordable for aquaculture producers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Autogenous Vaccine For Aquaculture Market Research Report
By Type
Bacteria Pathogen, Virus Pathogen
By Application
Aquatic Research Institute, Fish Farming Companies
By Companies
IDT Biologika GmbH (Ridgeway Biologicals Ltd), MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.), Ceva Biovac, Zoetis (PHARMAQAS), Vaxxinova, Barramundi Asia Pte Ltd.(UVAXX Asia), HIPRA, AniCon Labor GmbH, sanphar (ipeve), Kennebec River Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Autogenous Vaccine For Aquaculture Market Report Segments:
The global Autogenous Vaccine For Aquaculture market is segmented on the basis of:
Types
Bacteria Pathogen, Virus Pathogen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Aquatic Research Institute, Fish Farming Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- IDT Biologika GmbH (Ridgeway Biologicals Ltd)
- MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.)
- Ceva Biovac
- Zoetis (PHARMAQAS)
- Vaxxinova
- Barramundi Asia Pte Ltd.(UVAXX Asia)
- HIPRA
- AniCon Labor GmbH
- sanphar (ipeve)
- Kennebec River Biosciences
Highlights of The Autogenous Vaccine For Aquaculture Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bacteria Pathogen
- Virus Pathogen
- By Application:
- Aquatic Research Institute
- Fish Farming Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autogenous Vaccine For Aquaculture Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An autogenous vaccine is a vaccine that is made from the same strain of virus or bacteria used to cause the disease in humans. This type of vaccine is more effective because it helps build immunity against the virus or bacteria using methods similar to how people naturally develop immunity.
Some of the major companies in the autogenous vaccine for aquaculture market are IDT Biologika GmbH (Ridgeway Biologicals Ltd), MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.), Ceva Biovac, Zoetis (PHARMAQAS), Vaxxinova, Barramundi Asia Pte Ltd.(UVAXX Asia), HIPRA, AniCon Labor GmbH, sanphar (ipeve), Kennebec River Biosciences.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autogenous Vaccine For Aquaculture Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autogenous Vaccine For Aquaculture Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autogenous Vaccine For Aquaculture Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autogenous Vaccine For Aquaculture Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autogenous Vaccine For Aquaculture Market Size & Forecast, 2018-2028
4.5.1 Autogenous Vaccine For Aquaculture Market Size and Y-o-Y Growth
4.5.2 Autogenous Vaccine For Aquaculture Market Absolute $ Opportunity
Chapter 5 Global Autogenous Vaccine For Aquaculture Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Autogenous Vaccine For Aquaculture Market Size Forecast by Type
5.2.1 Bacteria Pathogen
5.2.2 Virus Pathogen
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Autogenous Vaccine For Aquaculture Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Autogenous Vaccine For Aquaculture Market Size Forecast by Applications
6.2.1 Aquatic Research Institute
6.2.2 Fish Farming Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autogenous Vaccine For Aquaculture Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autogenous Vaccine For Aquaculture Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Autogenous Vaccine For Aquaculture Analysis and Forecast
9.1 Introduction
9.2 North America Autogenous Vaccine For Aquaculture Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Autogenous Vaccine For Aquaculture Market Size Forecast by Type
9.6.1 Bacteria Pathogen
9.6.2 Virus Pathogen
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Autogenous Vaccine For Aquaculture Market Size Forecast by Applications
9.10.1 Aquatic Research Institute
9.10.2 Fish Farming Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Autogenous Vaccine For Aquaculture Analysis and Forecast
10.1 Introduction
10.2 Europe Autogenous Vaccine For Aquaculture Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Autogenous Vaccine For Aquaculture Market Size Forecast by Type
10.6.1 Bacteria Pathogen
10.6.2 Virus Pathogen
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Autogenous Vaccine For Aquaculture Market Size Forecast by Applications
10.10.1 Aquatic Research Institute
10.10.2 Fish Farming Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Autogenous Vaccine For Aquaculture Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Autogenous Vaccine For Aquaculture Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Autogenous Vaccine For Aquaculture Market Size Forecast by Type
11.6.1 Bacteria Pathogen
11.6.2 Virus Pathogen
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Autogenous Vaccine For Aquaculture Market Size Forecast by Applications
11.10.1 Aquatic Research Institute
11.10.2 Fish Farming Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Autogenous Vaccine For Aquaculture Analysis and Forecast
12.1 Introduction
12.2 Latin America Autogenous Vaccine For Aquaculture Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Autogenous Vaccine For Aquaculture Market Size Forecast by Type
12.6.1 Bacteria Pathogen
12.6.2 Virus Pathogen
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Autogenous Vaccine For Aquaculture Market Size Forecast by Applications
12.10.1 Aquatic Research Institute
12.10.2 Fish Farming Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Autogenous Vaccine For Aquaculture Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Autogenous Vaccine For Aquaculture Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Autogenous Vaccine For Aquaculture Market Size Forecast by Type
13.6.1 Bacteria Pathogen
13.6.2 Virus Pathogen
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Autogenous Vaccine For Aquaculture Market Size Forecast by Applications
13.10.1 Aquatic Research Institute
13.10.2 Fish Farming Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autogenous Vaccine For Aquaculture Market: Competitive Dashboard
14.2 Global Autogenous Vaccine For Aquaculture Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 IDT Biologika GmbH (Ridgeway Biologicals Ltd)
14.3.2 MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.)
14.3.3 Ceva Biovac
14.3.4 Zoetis (PHARMAQAS)
14.3.5 Vaxxinova
14.3.6 Barramundi Asia Pte Ltd.(UVAXX Asia)
14.3.7 HIPRA
14.3.8 AniCon Labor GmbH
14.3.9 sanphar (ipeve)
14.3.10 Kennebec River Biosciences
